Refeyn, a leading Life Science instrumentation company pioneering mass photometry, announced today that Gerry Mackay has been appointed the new CEO of the company effective January 1st, 2024. Over the Q4 2023 period, Gerry will transition into his new role working with Jonathan Flint, Executive Chairman and the Leadership Team at Refeyn. Gerry brings extensive […]

MINNEAPOLIS  — Bio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Jordan Laser has received the AMP Meritorious Service Award from the Association for Molecular Pathology (AMP). Dr. Laser is receiving this honor to recognize his dedication and effort behind the scenes to position AMP as the premier molecular diagnostics professional association around the world. Dr. […]

Today, LGC announced the appointment of David P. King as Non-Executive Chairman of its Board of Directors. Euan O’Sullivan, President & Chief Executive Officer (CEO) of LGC said: “We are delighted to welcome David to LGC’s Board of Directors, given his extensive healthcare experience within the diagnostics, pharmaceutical and biotech sectors, key customer focus areas […]

Industry Veteran Herman Cueto Named CFO Azenta CFO Lindon Robertson to Retire Company Reaffirms Guidance for Fourth Quarter Fiscal 2023 BURLINGTON, Mass., Sept. 26, 2023  Azenta, Inc. (Nasdaq: AZTA) today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer, effective October 16. Mr. Cueto, who comes from BD (Becton, Dickinson and Company, NYSE: BDX), will succeed […]

RADNOR, Pa., Sept. 26, 2023 – Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, today announced that Benoit Gourdier will join the company as EVP, Biopharma Production on October 2, 2023. Mr. Gourdier will succeed Dr. Ger Brophy, who will retire from […]

Board Will Accelerate Solutions for Life Sciences Customers; Includes Experts in Biologic Manufacturing Sciences and Technology, Chemistry and Gene Therapy RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services for customers in the life sciences and technology industries, today announced the creation of a new Scientific Advisory Board (SAB), […]

BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. “Amir’s leadership track record speaks for itself,” said Jeff Hawkins, CEO of Quantum-Si. “He has successfully managed businesses across multiple industries and has built and led […]

San Francisco, CA — Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner. “Mara brings more than 30 years of leadership experience in genomics and the diagnostics industry to this position,” said Nick Naclerio, PhD, Illumina Ventures Founding Partner. “Her experience ranges from early-stage start-ups to established public […]

Deepcell Expands Commercial Capabilities Hiring Mark Aitkenhead, Ph.D., as Chief Commercial Officer   MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoveries, today announced the appointment of Mark Aitkenhead, Ph.D., to the newly created position of Chief Commercial Officer. “We are delighted to welcome Dr. Aitkenhead to our […]

An innovative biotools company puts an experienced bioentrepreneur at the helm LOWER GWYNEDD, Pa. — ChromaTanTM announced today that Dr. Rajiv Datar has been appointed the new President & CEO of the company. A bioentrepreneur with over 25 years C-level experience in bioprocessing and drug development, Dr. Datar succeeds Oleg Shinkazh, the Founder of ChromaTan, who […]